Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

(1S,2S)-2-Methylamino-1-phenylpropanol hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

58 API Suppliers, 25 USDMF, 9 CEP/COS, 1 JDMF, 2 EU WC, 22 KDMF, 11 NDC API, 13 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

FINISHED DOSAGE FORMULATIONS

389 FDF Dossiers, 114 FDA Orange Book, 76 Europe, 112 Canada, 51 South Africa, 36 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG;30MG, CAPSULE;ORAL - 8MG;60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 240MG, TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG, CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT;30MG, TABLET;ORAL - 2MG;200MG;30MG, TABLET, EXTENDED RELEASE;ORAL - 1.2GM;120MG, TABLET, EXTENDED RELEASE;ORAL - 600MG;60MG, TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG, SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML;30MG/5ML, SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SYRUP;ORAL - 2MG/5ML;10MG/5ML;30MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 8 Rochem International Inc, 22 SPI Pharma, 15 DKSH, 2 Pharm-RX Chemical, 12 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 12 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 7 Kirsch Pharma, 4 ACG Worldwide, 15 Actylis, 4 Aeon Procare, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 38 BASF, 1 Bioplus Life Sciences, 3 CD Formulation, 2 Clariant, 12 Corel Pharma Chem, 7 DFE Pharma, 2 Esteem Industries, 2 Finar, 14 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 2 Lubrizol Life Science Health, 18 Microlex e.U, 2 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 37 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 1 Symrise, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

106 Fillers, Diluents & Binders, 58 Coating Systems & Additives, 53 Direct Compression, 49 Thickeners and Stabilizers, 47 Disintegrants & Superdisintegrants, 42 Granulation, 37 Taste Masking, 37 Solubilizers, 37 Controlled & Modified Release, 34 Topical, 33 Parenteral, 33 Film Formers & Plasticizers, 30 Lubricants & Glidants, 26 Chewable & Orodispersible Aids, 16 Co-Processed Excipients, 12 Emulsifying Agents, 12 Rheology Modifiers, 10 API Stability Enhancers, 9 Empty Capsules, 6 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 32 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 Regulatory FDF Prices

1 Regulatory FDF Prices

MARKET PLACE

27 APIs

27 APIs

PATENTS & EXCLUSIVITIES

1 US Patents, 7 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM

1 EDQM

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	Malladi Drugs & Pharmaceuticals Limited	India	Johnson & Johnson Korea Sales Co., Ltd.	20050831-41-C-46-03(4)	pseudoephedrine hydrochloride	2024-09-11	Malladi Drug & Pharmaceuticals Limited	India	7B&7C, SIPCOT Industrial Complex, Ranipet-632 403, Ranipet District, Tamil Nadu, India
29/11/2025	Malladi Drugs & Pharmaceuticals Limited	India	Samil Pharmaceutical Co., Ltd.	20050831-41-C-46-03(3)	pseudoephedrine hydrochloride	2013-09-12	Malladi Drug & Pharmaceuticals Limited	India	7B&7C, SIPCOT Industrial Complex, Ranipet-632 403, Ranipet District, Tamil Nadu, India

(1S,2S)-2-Methylamino-1-phenylpropanol Hydrochloride

(1S,2S)-2-Methylamino-1-phenylpropanol hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

58 API Suppliers

25 USDMF

9 CEP/COS

1 JDMF

2 EU WC

22 KDMF

11 NDC API

13 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

12 Drugs in Development

FINISHED DOSAGE FORMULATIONS

389 FDF Dossiers

114 FDA Orange Book

76 Europe

112 Canada

51 South Africa

36 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG;30MG

CAPSULE;ORAL - 8MG;60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 240MG

TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG

CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT;30MG

TABLET;ORAL - 2MG;200MG;30MG

TABLET, EXTENDED RELEASE;ORAL - 1.2GM;120MG

TABLET, EXTENDED RELEASE;ORAL - 600MG;60MG

TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG

SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML;30MG/5ML

SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;ORAL - 5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SYRUP;ORAL - 2MG/5ML;10MG/5ML;30MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

8 Rochem International Inc

22 SPI Pharma

15 DKSH

2 Pharm-RX Chemical

12 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

12 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

7 Kirsch Pharma

4 ACG Worldwide

15 Actylis

4 Aeon Procare

2 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

38 BASF

1 Bioplus Life Sciences

3 CD Formulation

2 Clariant

12 Corel Pharma Chem

7 DFE Pharma

2 Esteem Industries

2 Finar

14 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

5 Ideal Cures

5 Ingredion Pharma Solutions

26 Kerry

3 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

2 Lubrizol Life Science Health

18 Microlex e.U

2 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

5 Novo Excipients

CAPSULE;ORAL - 8MG;60MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;ORAL - 5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons